Rating History for Protara Therapeutics (TARA) by JPMorgan
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 3/4/2026 | Brian Cheng | New Coverage | Overweight (N/A) |
27.00 (N/A) |
5.97 (5.97) |
0% | Details |
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 3/4/2026 | Brian Cheng | New Coverage | Overweight (N/A) |
27.00 (N/A) |
5.97 (5.97) |
0% | Details |
![]() |
|||||||